Rajaraman Preetha, Doody Michele M, Yu Chu Ling, Preston Dale L, Miller Jeremy S, Sigurdson Alice J, Freedman D Michal, Alexander Bruce H, Little Mark P, Miller Donald L, Linet Martha S
1 Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U. S. Department of Health and Human Services, 9609 Medical Center Dr, Rockville, MD 20892-9778.
2 Center for Global Health, National Cancer Institute, National Institutes of Health, U. S. Department of Health and Human Services, Rockville, MD.
AJR Am J Roentgenol. 2016 May;206(5):1101-8; quiz 1109. doi: 10.2214/AJR.15.15265. Epub 2016 Mar 21.
The purpose of this study was to examine risks of cancer incidence and mortality among U.S. radiation technologists performing or assisting with fluoroscopically guided interventional procedures.
A nationwide prospective cohort of 90,957 radiologic technologists, who responded to a 1994-1998 survey that collected information on whether they had ever worked with fluoroscopically guided interventional procedures, was followed through completion of a subsequent cohort survey during 2003-2005 (for cancer incidence) or December 31, 2008 (for cancer mortality). Sex-adjusted hazard ratios (HRs) and 95% CIs were calculated by use of Cox proportional hazards models for incidence and mortality from all cancers other than nonmelanoma skin cancer and for specific cancer outcomes in participants who reported ever performing fluoroscopically guided interventional procedures compared with technologists who never performed these procedures.
The analysis showed an approximately twofold increased risk of brain cancer mortality (HR, 2.55; 95% CI, 1.48-4.40) and modest elevations in incidence of melanoma (HR, 1.30; 95% CI, 1.05-1.61) and in breast cancer incidence (HR, 1.16; 95% CI, 1.02-1.32) but not mortality (HR, 1.07; 95% CI, 0.69-1.66) among technologists who performed fluoroscopically guided interventional procedures compared with those who never performed these procedures. Although there was a small suggestive increase in incidence of all cancers combined, excluding nonmelanoma skin cancers (HR, 1.08; 95% CI, 1.00-1.17), mortality from all cancers combined, excluding nonmelanoma skin cancers, was not elevated (HR, 1.00; 95% CI, 0.88-1.14). We similarly observed no elevated risk of cancers of the thyroid, skin other than melanoma, prostate, lung, or colon and rectum or of leukemia that was not chronic lymphocytic leukemia among workers who performed fluoroscopically guided interventional procedures.
We observed elevated risks of brain cancer, breast cancer, and melanoma among technologists who performed fluoroscopically guided interventional procedures. Although exposure to low-dose radiation is one possible explanation for these increased risks, these results may also be due to chance or unmeasured confounding by nonradiation risk factors. Our results must be confirmed in other studies, preferably with individual radiation dose data.
本研究旨在调查在美国进行或协助荧光透视引导介入手术的放射技师中癌症发病率和死亡率的风险。
对90957名放射技师进行了一项全国性前瞻性队列研究,这些技师回应了1994 - 1998年的一项调查,该调查收集了他们是否曾参与荧光透视引导介入手术的信息。随后在2003 - 2005年(用于癌症发病率)或2008年12月31日(用于癌症死亡率)完成了后续队列调查。通过Cox比例风险模型计算性别调整后的风险比(HR)和95%置信区间(CI),以评估报告曾进行荧光透视引导介入手术的参与者与从未进行过这些手术的技师相比,所有非黑色素瘤皮肤癌以外癌症的发病率和死亡率以及特定癌症结局的情况。
分析显示,与从未进行过这些手术的技师相比,进行荧光透视引导介入手术的技师患脑癌死亡率的风险增加了约两倍(HR,2.55;95% CI,1.48 - 4.40),黑色素瘤发病率有适度升高(HR,1.30;95% CI,1.05 - 1.61),乳腺癌发病率也有升高(HR,1.16;95% CI,1.02 - 1.32),但死亡率未升高(HR,1.07;95% CI,0.69 - 1.66)。尽管排除非黑色素瘤皮肤癌后,所有癌症合并发病率有小幅提示性升高(HR,1.08;95% CI,1.00 - 1.17),但排除非黑色素瘤皮肤癌后所有癌症合并死亡率未升高(HR,1.00;95% CI,0.88 - 1.14)。同样,我们观察到进行荧光透视引导介入手术的工作人员患甲状腺癌、非黑色素瘤皮肤癌以外的皮肤癌、前列腺癌、肺癌、结肠癌和直肠癌或非慢性淋巴细胞白血病的白血病的风险没有升高。
我们观察到进行荧光透视引导介入手术的技师患脑癌、乳腺癌和黑色素瘤的风险升高。虽然低剂量辐射暴露是这些风险增加的一种可能解释,但这些结果也可能是由于偶然因素或未测量的非辐射风险因素的混杂作用。我们的结果必须在其他研究中得到证实,最好有个体辐射剂量数据。